Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Activities of Daily Living and Upper Extremity Exercise Capacity of Individuals with High Body Mass Index

NCT06745310 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2024-12-12
Last updated
2024-12-20

Condition(s) studied

Body Mass IndexBody Mass Index 25 or GreaterBody Mass Index, Normal

Study summary

Individuals with high and normal body mass index will be included in this study.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria for individuals with high body mass index: * Body mass index ≥ 25 kg/m2 * Volunteering for the study Exclusion Criteria for individuals with high body mass index: * Having uncontrolled hypertension, diabetes mellitus * Having comorbidities that may affect physical functions * Failure to cooperate with tests to be performed * Liver disease, kidney disease, cancer, lung diseases and serious cardiomyopathies, neurological diseases * Pregnancy * Having a history of bariatric surgery * Presence of contraindications to exercise testing Inclusion Criteria for individuals with normal body mass index: * Body mass index 18.5-24.9 kg/m2 * Volunteering for the study Exclusion Criteria for individuals with normal body mass index: * Body mass index \> 25 kg/m2 or ≤18.5 kg/m2 * Having a known chronic or systemic disease * Failure to cooperate with tests to be performed

Primary outcome measure(s)

  • Upper extremity exercise capacity — 1st day
    It will be assessed by 6 minute pegboard and ring test.
  • Daily living activities — 1st day
    It will be evaluated with the Glittre activities of daily living test.

Trial sites (1)

FacilityCityRegionStatus
Kirsehir Ahi Evran University Kırşehir Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06745310 on ClinicalTrials.gov ↗ ← All trials in Turkey